HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Assessment of the dose distribution of Minibeam radiotherapy for lung tumors in an anthropomorphic phantom: A feasibility study.

AbstractBACKGROUND:
Microbeam radiotherapy (MRT) is a treatment in which radiation field is divided into several separate fields of 10-100 μm width and 100-400 μm spacing. In this treatment, normal tissue can tolerate high doses that are delivered to its small volumes.
OBJECTIVE:
MCNPX 2.4 Monte Carlo code was used to calculate the dose distribution of MRT in a lung tumor in a simulated Rando phantom.
METHODS:
The effects of tissue inhomogeneities, using contrast media and changing the number of beams were investigated. Dose volume histograms and beam profiles of target and organs at risk were assessed and the dose uniformity in the target region was evaluated using homogeneity. The conformity indices also used to quantify the conformation of the shape of prescribed isodose volume to the shape and size of the target.
RESULTS:
Tissue inhomogeneity of this region did not interfere significantly with target dose homogeneity. The use of contrast media or increasing the number of beams improved target dose homogeneity and decreased the dose to surrounding tissues.
CONCLUSIONS:
The results suggest that further investigation and evaluation of MRT for treatment of chest tumors is worthwhile.
AuthorsBanafsheh Zeinali-Rafsanjani, Mohammad Amin Mosleh-Shirazi, Mahdi Haghighatafshar, Reza Jalli, Mahdi Saeedi-Moghadam
JournalTechnology and health care : official journal of the European Society for Engineering and Medicine (Technol Health Care) Vol. 25 Issue 4 Pg. 683-692 (Aug 09 2017) ISSN: 1878-7401 [Electronic] Netherlands
PMID28506005 (Publication Type: Journal Article)
Topics
  • Computer Simulation
  • Feasibility Studies
  • Humans
  • Lung Neoplasms (radiotherapy)
  • Models, Anatomic
  • Monte Carlo Method
  • Phantoms, Imaging
  • Radiation Dosage
  • Radiotherapy Planning, Computer-Assisted (methods)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: